Bicalutamide

Bicalutamide is a medicine for prostate cancer that has spread. It is taken as a pill by mouth, together with another hormone treatment. It works by blocking male hormones like testosterone from reaching the cancer cells, which helps slow their growth.

Brand names:Casodex
Medication

What people taking Bicalutamide report

Every report comes from a Lived member, sent anonymously.

Have you tried Bicalutamide for Prostate Cancer?

NameHow it went

About Bicalutamide

What It's For

Bicalutamide, sold under the brand name Casodex and as a generic, is a prescription tablet used to treat prostate cancer that has spread beyond the prostate to other parts of the body (metastatic prostate cancer). It is approved for use together with a luteinizing hormone-releasing hormone (LHRH) analog, a hormone treatment such as leuprolide or goserelin that is given as an injection or implant and lowers the amount of testosterone the testicles make. Bicalutamide belongs to a group of medicines called antiandrogens. In the US it is approved only at a 50 mg daily dose and only in combination with that hormone treatment. It is not approved for use on its own or at a higher 150 mg dose. In studies, using an antiandrogen alone in place of testosterone-lowering treatment led to shorter survival, and adding the higher dose to standard care for earlier-stage prostate cancer did not help people live longer. An antiandrogen may also be given around the start of an LHRH agonist to prevent tumor flare, a short-lived worsening of cancer symptoms that can happen before testosterone levels fall.

How It Works

Most prostate cancers depend on androgens, male hormones such as testosterone, to grow. Androgens act by attaching to androgen receptors in prostate cancer cells, which switches on signals that drive the cells to grow. Bicalutamide attaches to those receptors instead, so androgens cannot act on them. This is why it is paired with an LHRH analog. The LHRH analog sharply lowers the testosterone the testicles make, while bicalutamide blocks the effect of the androgens that remain. Bicalutamide does not lower testosterone by itself, and in studies where it was used alone, testosterone levels actually rose. Used together, the two treatments attack the cancer's hormone supply from two directions.

Dosage & Administration

Bicalutamide is a 50 mg tablet taken by mouth once a day, in the morning or evening, with or without food. Taking it at the same time each day makes it easier to remember. It is started at the same time as the LHRH analog, which is given separately on its own injection or implant schedule. If a dose is missed, skip it and take the next one at the usual time; do not take two doses to make up for it. Do not stop or pause bicalutamide or the LHRH analog without talking to the prescriber first.

Side Effects

Hot flashes are the most common side effect, affecting about half of people taking bicalutamide with an LHRH analog. Many of the effects people notice come from the overall drop in hormone activity: tiredness and weakness, lower sex drive and erection problems, breast tenderness or enlargement, and changes in weight. Other common effects include constipation, nausea, diarrhea, back or pelvic pain, swelling in the legs, and needing to urinate at night. Some people feel sleepy, so take care with driving until you know how it affects you. Skin can become more sensitive to sunlight, so sunscreen and limiting strong sun exposure help. Bicalutamide can rarely cause serious liver damage, which has occasionally been fatal. It usually appears in the first three to four months. Liver blood tests are done before starting, regularly during the first four months and from time to time after that. Contact the care team right away about yellowing of the skin or eyes (jaundice), dark urine, pain in the upper right side of the abdomen, or new nausea, vomiting, loss of appetite or flu-like symptoms. Inflammation and scarring of the lungs (interstitial lung disease) has been reported, mostly at doses higher than the approved 50 mg. New or worsening shortness of breath or a persistent cough should be reported promptly. Hives or swelling of the face, lips or throat can signal an allergic reaction and should also be reported right away.

Interactions & Warnings

For people who take warfarin, a blood thinner, bicalutamide can strengthen warfarin's effect, sometimes days to weeks after starting. Serious bleeding has occurred, including in the brain and digestive tract. The INR (international normalized ratio), the blood test that shows how long blood takes to clot, should be checked closely after bicalutamide is started, and the warfarin dose may need adjusting. Report any unusual bleeding or bruising promptly. Bicalutamide also slows the liver's breakdown of some other medicines, which can raise their levels. The prescriber and pharmacist should review everything you take, including over-the-counter medicines and supplements. People with existing liver disease need extra caution because of the liver risk described above. The LHRH analog that goes with bicalutamide can raise blood sugar, sometimes causing diabetes or making existing diabetes harder to control, so blood sugar may be monitored during treatment. Bicalutamide is not used by women and can harm a developing baby. Men whose partners could become pregnant should use effective contraception during treatment and for 130 days after the last dose. It may also reduce fertility, which is worth discussing before treatment if future children matter.

What to Expect

Bicalutamide is usually taken long term, alongside the LHRH analog, for as long as the cancer stays controlled and side effects are manageable. Response is followed mainly with PSA (prostate-specific antigen), a blood test for a protein made by prostate cells. A falling or low PSA suggests the cancer is responding. A rising PSA prompts the care team to check whether the cancer is growing. Expect regular visits with blood tests, especially liver tests in the first months. Hot flashes and other hormone-related effects often continue for as long as treatment does. If the cancer progresses, the plan changes. In some people, stopping bicalutamide while continuing the LHRH analog brings a temporary drop in PSA or an improvement in symptoms, known as antiandrogen withdrawal, and the care team may try this before or alongside moving to other treatments.

Questions to Ask Your Doctor

  1. 1.Why is bicalutamide being added to my LHRH treatment, and is it for the long term or only to prevent flare at the start?
  2. 2.How often will my liver tests and PSA be checked, and what results would change the plan?
  3. 3.What can we do about hot flashes, breast changes or other hormone-related side effects if they become a problem?
  4. 4.I take warfarin or other regular medicines; what needs to be checked or adjusted when I start bicalutamide?
  5. 5.If my PSA starts to rise, what are the next options?

Last reviewed • Oct 2026

Educational content, not medical advice.